RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DE NICOLò A
Collezione ASL Città di Torino

Items : 70

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.

2024
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Stroffolini G; Lupia T; De Nicolò A; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Boglione L; Cusato J;

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.

2024
ASL Città di Torino

Calcagno A; D'Avolio A; Ponzetta L; Marinaro L; Alladio F; Cat Genova E; Quaranta M; Stroffolini G; Gaviraghi A; de Nicolò A; Venuti F;

Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.

2023
ASL Città di Torino

Bonora S; Calcagno A; Marchiaro C; D'Avolio A; Cinnirella G; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Stroffolini G; Gaviraghi A; Longo BM; De Nicolò A; Venuti F;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.

2022
ASL Città di Torino
AOU San Luigi di Orbassano

Calcagno A; Rosa FG; Di Perri G; Chiara F; Antonucci M; De Nicolò A; Allegra S; De Francia S; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.

2022
ASL Città di Torino

Smedile A; D'Avolio A; Cantù M; Di Perri G; Saracco GM; Cariti G; Manca A; Mula J; Antonucci M; Ciancio A; Palermiti A; Avataneo V; Troshina G; Caviglia GP; Mornese Pinna S; De Nicolò A; Boglione L; Cusato J;

A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.

2022
ASL Città di Torino

Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;

Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from "Integriamoci", a Pilot Pharmacokinetic Study. in Molecules (Basel, Switzerland) / Molecules. 2022 Feb 3;27(3):1042. doi: 10.3390/molecules27031042.

2022
ASL Città di Torino

Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;

A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2022 Feb 19:1-8. doi: 10.1007/s11845-022-02952-9.

2022
ASL Città di Torino

Sanson G; De Nicolò A; Zerbato V; Segat L; Koncan R; Di Bella S; Cusato J; di Masi A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;

A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.

2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; De Cori D; Cusato J; Vischia F; Imperiale D; De Filippis G; De Nicolò A; Zeaiter S; Palermiti A; Maiese D; Mula J; Chiara F; Manca A;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants in Pharmaceuticals

2022
ASL Città di Torino

Mula J; Antonucci M; De Nicolò A; Allegra S; De Francia S; Chiara F; Di Perri G; De Rosa FG; Calcagno A; Cusato J; Palermiti A; Manca A; D’avolio A;

Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy in Journal of preventive medicine and hygiene

2022
ASL Città di Torino

Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;

Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study. in Therapie / Therapie. 2021 Sep-Oct;76(5):409-414. doi: 10.1016/j.therap.2020.10.003. Epub 2020 Oct 23.

2021
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; D'Avolio A; Romeo MR; Di Perri G; Stella M; Corgiat Loia R; Corcione S; De Nicolò A; Lupia T; Segala FV; Pensa A;

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.

2021
ASL Città di Torino

Di Perri G; De Nicolò A; D'Avolio A; Calcagno A; Ianniello A; De Vivo ED; Avataneo V; Cusato J; Mula J; Antonucci M; Manca A; Palermiti A;

Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.

2021
ASL Città di Torino

D'Avolio A; Tempestilli M; De Nicolò A; Agrati C; Antinori A; Cicalini S;

Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.

2021
ASL Città di Torino

Barco S; Cafaro A; Palermiti A; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;

Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.

2021
ASL Città di Torino

Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe

2021
ASL Città di Torino

Calcagno A; Di Perri G; Bonora S; Piccioni P; D'Avolio A; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Trentalange A; Motta I; Borgogno E;

Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients. in Scientific reports / Sci Rep. 2021 Jan 11;11(1):443. doi: 10.1038/s41598-020-79574-7.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Romagnoli R; Dell'Olio D; Catalano S; Tandoi F; Canaparo R; Calvo PL; Serpe L; Pizzol A; Antonucci M; D'Avolio A; Pinon M; De Nicolò A;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26

2021
ASL Città di Torino

Di Perri G; D'Avolio A; Bonora S; de Nicolò A; Gervasoni C; Mistrangelo M; Testi R; Cattaneo D; Calcagno A; Dal Conte I;

Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.

2021
ASL Città di Torino

Scabini S; Montrucchio G; De Nicolò A; Corcione S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;

A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; Rabbia F; Fanelli E; De Nicolò A; Avataneo V;

Observed concentrations of amikacin and gentamycin in the setting of burn patients with gram-negative bacterial infections: Preliminary data from a prospective study in Therapies

2021
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; D'Avolio A; Stella M; Di Perri G; Romeo MR; Corgiat Loia R; Pensa A; Segala FV; Lupia T; De Nicolò A; Corcione S;

Low tenofovir plasma exposure in HIV oral pre-exposure prophylaxis recipients with gastrointestinal disorders in Antimicrobial Agents and Chemotherapy

2021
ASL Città di Torino

D'Avolio A; Di Perri G; Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S;

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.

2020
ASL Città di Torino

Avataneo V; D'Avolio A; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;

Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.

2020
ASL Città di Torino

De Rosa FG; Stella M; Di Perri G; De Nicolò A; Romeo M; Fatiguso G; Segala FV; Corcione S; D'Avolio A; Pensa A; Loia RC;

Data on the stability of darunavir/cobicistat suspension after tablet manipulation. in Data in brief / Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.

2020
ASL Città di Torino

Minghetti P; Tomasello C; Maximova N; Cilurzo F; Musazzi UM; Zanon D; D'Avolio A; Manca A; De Nicolò A;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.

2020
ASL Città di Torino

D'Avolio A; Antonucci M; Manca A; Avataneo V; Allegra S; De Francia S; De Nicolò A; Cusato J;

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Jul 1;75(7):1772-1777. doi: 10.1093/jac/dkaa152.

2020
ASL Città di Torino

de Nicolò A; Avataneo V; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis. in Journal of infection and public health / J Infect Public Health. 2020 Feb;13(2):315-316. doi: 10.1016/j.jiph.2019.12.005. Epub 2020 Jan 15.

2020
ASL Città di Torino

Boglione L; De Benedetto I; Salvador E; Lupia T; De Nicolò A; Di Perri G; Lipani F; Lucchini AM;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.

2020
ASL Città di Torino

Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients. in Data in brief / Data Brief. 2020 Dec;33:106445. doi: 10.1016/j.dib.2020.106445. Epub 2020 Oct 23.

2020
ASL Città di Torino

Minghetti P; Clementi E; Tomasello C; Maximova N; Cilurzo F; D'Avolio A; De Nicolò A; Zanon D; Musazzi UM; Manca A;

Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation in International Journal of Antimicrobial Agents

2020
ASL Città di Torino

Calcagno A; Di Perri G; Celani L; Bonora S; D'Avolio A; Tettoni M; Lazzaro A; D'Ascenzo F; D'Ettorre G; De Nicolò A; Montrucchio C;

Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica

2020
ASL Città di Torino

Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.

2019
AOU San Luigi di Orbassano
ASL Città di Torino

Piga A; Avataneo V; De Nicolò A; Massano D; Pirro E; Longo F; Cusato J; De Francia S; D'Avolio A; Allegra S;

LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.

2019
ASL Città di Torino

Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;

Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20

2019
ASL Città di Torino

Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;

Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. in Neurocritical care / Neurocrit Care. 2019 Aug;31(1):116-124. doi: 10.1007/s12028-018-0657-y.

2019
ASL Città di Torino

Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A;

Antiretrovirals concentrations in the olfactory mucosa of hivpositive patients in Topics in Antiviral Medicine

2019
ASL Città di Torino

Calcagno A; De Nicolò A; Trunfio M; Allice T; Imperiale D; Bartoli C; Ghisetti V; Amasio ME; D'Avolio A; Di Perri G; Bonora S;

Flecainide plasma level modifications during ledipasvir/sofosbuvir coadministration in two patients affected by chronic hepatitis C. in Antiviral therapy / Antivir Ther. 2019;24(7):553-555. doi: 10.3851/IMP3328.

2019
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201

2018
AOU Città della Salute di Torino
ASL Città di Torino

Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.

2018
AOU Città della Salute di Torino
ASL Città di Torino

D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.

2018
AOU San Luigi di Orbassano
ASL Città di Torino

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A;

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22

2018
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.

2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.

2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.

2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.

2018
ASL Città di Torino

D'Avolio A; Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; Carcieri C;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.

2018
ASL Città di Torino

Cusato J; Carcieri C; De Nicolò A; Di Perri G; D'Avolio A; Allegra S; Fatiguso G; Pirro E; Favata F; De Francia S;

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.

2018
ASL Città di Torino

Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.

2018
ASL Città di Torino

Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients in Pharmacogenetics and Genomics

2018
ASL Città di Torino

D'Avolio A; Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S;

Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. in Antiviral therapy / Antivir Ther. 2018;23(4):373-377. doi: 10.3851/IMP3207.

2018
ASL Città di Torino

De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;

The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.

2017
ASL Città di Torino

El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;

A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.

2017
ASL Città di Torino

Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;

Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.

2017
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. in Journal of clinical pharmacy and therapeutics / J Clin Pharm Ther. 2017 Oct;42(5):621-623. doi: 10.1111/jcpt.12546. Epub 2017 May 4.

2017
ASL Città di Torino

Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G;

Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.

2017
ASL Città di Torino

Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.

2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; De Nicolò A; Di Perri G; Cusato J; Pirro E; Carcieri C; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5

2017
ASL Città di Torino

D'Avolio A; Cusato J; Di Perri G; De Nicolò A; De Francia S; Carcieri C; Pirro E; Favata F; Fatiguso G; Allegra S;

UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:223-230. doi: 10.1016/j.jpba.2017.02.002. Epub 2017 Feb 3.

2017
ASL Città di Torino

Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.

2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.

2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

First UHPLC-MS/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients. in Journal of mass spectrometry : JMS / J Mass Spectrom. 2017 Mar;52(3):187-195. doi: 10.1002/jms.3909.

2017
AOU Città della Salute di Torino
ASL Città di Torino

Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;

Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.

2017
ASL Città di Torino

Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. in Bioanalysis / Bioanalysis. 2017 Jul;9(14):1093-1105. doi: 10.4155/bio-2017-0059. Epub 2017 Jul 24.

2017
ASL Città di Torino

De Nicolò A; Cantù M; D'Avolio A;

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.

2017
ASL Città di Torino

Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.

2017
ASL Città di Torino

Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.

2017
AOU Città della Salute di Torino
ASL Città di Torino

D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V;

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. in International journal of pharmaceutical compounding / Int J Pharm Compd. 2016 Jul-Aug;20(4):343-346.

2016
ASL Città di Torino
AOU Città della Salute di Torino

De Perri G; De Nicolò A; Fulcheri C; Baietto L; Veglio F; Rabbia F; Leggieri A; Tomasello C; D'Avolio A;

UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.

2016
ASL Città di Torino

Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A;